195 related articles for article (PubMed ID: 23741431)
1. ApoE4 induces synaptic and ERG impairments in the retina of young targeted replacement apoE4 mice.
Antes R; Ezra-Elia R; Weinberger D; Solomon A; Ofri R; Michaelson DM
PLoS One; 2013; 8(5):e64949. PubMed ID: 23741431
[TBL] [Abstract][Full Text] [Related]
2. VEGF Mediates ApoE4-Induced Neovascularization and Synaptic Pathology in the Choroid and Retina.
Antes R; Salomon-Zimri S; Beck SC; Garcia Garrido M; Livnat T; Maharshak I; Kadar T; Seeliger M; Weinberger D; Michaelson DM
Curr Alzheimer Res; 2015; 12(4):323-34. PubMed ID: 25817253
[TBL] [Abstract][Full Text] [Related]
3. ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice.
Liraz O; Boehm-Cagan A; Michaelson DM
Mol Neurodegener; 2013 May; 8():16. PubMed ID: 23684315
[TBL] [Abstract][Full Text] [Related]
4. The effects of the apoE4 genotype on the developing mouse retina.
Maharshak I; Salomon-Zimri S; Antes R; Liraz O; Nisgav Y; Livnat T; Weinberger D; Colton CA; Solomon AS; Michaelson DM
Exp Eye Res; 2016 Apr; 145():17-25. PubMed ID: 26554939
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E4 reduces evoked hippocampal acetylcholine release in adult mice.
Dolejší E; Liraz O; Rudajev V; Zimčík P; Doležal V; Michaelson DM
J Neurochem; 2016 Feb; 136(3):503-9. PubMed ID: 26526158
[TBL] [Abstract][Full Text] [Related]
6. Reversal of ApoE4-Driven Brain Pathology by Vascular Endothelial Growth Factor Treatment.
Salomon-Zimri S; Glat MJ; Barhum Y; Luz I; Boehm-Cagan A; Liraz O; Ben-Zur T; Offen D; Michaelson DM
J Alzheimers Dis; 2016 Jun; 53(4):1443-58. PubMed ID: 27372644
[TBL] [Abstract][Full Text] [Related]
7. Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology.
Koren-Iton A; Salomon-Zimri S; Smolar A; Shavit-Stein E; Dori A; Chapman J; Michaelson DM
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075060
[TBL] [Abstract][Full Text] [Related]
8. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.
Levi O; Dolev I; Belinson H; Michaelson DM
J Neurochem; 2007 Nov; 103(3):1031-40. PubMed ID: 17666042
[TBL] [Abstract][Full Text] [Related]
9. Extra-Hippocampal Learning Deficits in Young Apolipoprotein E4 Mice and Their Synaptic Underpinning.
Har-Paz I; Roisman N; Michaelson DM; Moran A
J Alzheimers Dis; 2019; 72(1):71-82. PubMed ID: 31561365
[TBL] [Abstract][Full Text] [Related]
10. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R
J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429
[TBL] [Abstract][Full Text] [Related]
11. Progressive loss of synaptic integrity in human apolipoprotein E4 targeted replacement mice and attenuation by apolipoprotein E2.
Klein RC; Mace BE; Moore SD; Sullivan PM
Neuroscience; 2010 Dec; 171(4):1265-72. PubMed ID: 20951774
[TBL] [Abstract][Full Text] [Related]
12. The Effects of APOE4 on Mitochondrial Dynamics and Proteins in vivo.
Simonovitch S; Schmukler E; Masliah E; Pinkas-Kramarski R; Michaelson DM
J Alzheimers Dis; 2019; 70(3):861-875. PubMed ID: 31306119
[TBL] [Abstract][Full Text] [Related]
13. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
[TBL] [Abstract][Full Text] [Related]
14. The isoform-specific pathological effects of apoE4 in vivo are prevented by a fish oil (DHA) diet and are modified by cholesterol.
Kariv-Inbal Z; Yacobson S; Berkecz R; Peter M; Janaky T; Lütjohann D; Broersen LM; Hartmann T; Michaelson DM
J Alzheimers Dis; 2012; 28(3):667-83. PubMed ID: 22057027
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E3 (ApoE3) but not ApoE4 protects against synaptic loss through increased expression of protein kinase C epsilon.
Sen A; Alkon DL; Nelson TJ
J Biol Chem; 2012 May; 287(19):15947-58. PubMed ID: 22427674
[TBL] [Abstract][Full Text] [Related]
16. Altered neurotransmission in the lateral amygdala in aged human apoE4 targeted replacement mice.
Klein RC; Acheson SK; Mace BE; Sullivan PM; Moore SD
Neurobiol Aging; 2014 Sep; 35(9):2046-52. PubMed ID: 24698766
[TBL] [Abstract][Full Text] [Related]
17. Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficits.
Belinson H; Lev D; Masliah E; Michaelson DM
J Neurosci; 2008 Apr; 28(18):4690-701. PubMed ID: 18448646
[TBL] [Abstract][Full Text] [Related]
18. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
[TBL] [Abstract][Full Text] [Related]
19. Hippocampal synaptic and neural network deficits in young mice carrying the human APOE4 gene.
Sun GZ; He YC; Ma XK; Li ST; Chen DJ; Gao M; Qiu SF; Yin JX; Shi J; Wu J
CNS Neurosci Ther; 2017 Sep; 23(9):748-758. PubMed ID: 28786172
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E4 causes early olfactory network abnormalities and short-term olfactory memory impairments.
Peng KY; Mathews PM; Levy E; Wilson DA
Neuroscience; 2017 Feb; 343():364-371. PubMed ID: 28003161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
